An FDA-cleared, prescription-only non-invasive cervical VNS device for specific headache disorders — a clinical tool, not a consumer wellness device.Best for clinically-indicated migraine or cluster-headache patients — an FDA-cleared, prescription-only cervical VNS device.
gammaCore is the FDA-cleared non-invasive cervical vagus nerve stimulator for headache disorders — migraine (prevention and acute treatment, age 12+), cluster headache, paroxysmal hemicrania and hemicrania continua. It is a handheld device pressed against the side of the neck over the carotid artery, delivering a proprietary 5 kHz waveform burst for 2-minute sessions. Available by prescription only. Within its indications it has the most headache RCTs here, mostly maker-sponsored (which ONDA does not count) — and it is priced and gated accordingly.
How we tested: Evidence-based assessment — scored from electroCore clinical documentation, FDA-cleared labelling, and the published gammaCore randomised-trial record. Not hands-on tested by ONDA.
FDA-cleared for migraine prevention and acute treatment (age 12+), cluster headache, paroxysmal hemicrania and hemicrania continua. The pivotal randomised trials were sponsored by electroCore, and maker-sponsored studies do not count as evidence in ONDA scores; independent trials remain, so it is still the clinical reference for non-invasive cervical VNS.
Stimulation mechanism
8.5
Cervical tVNS over the carotid sheath — targets the cervical vagal trunk directly. Proprietary 5 kHz burst waveform; parameters are fixed, not user-adjustable.
Protocol flexibility
5.5
Two-minute fixed sessions, dose set by prescriber. No programme variety — by design, since dosing is clinically calibrated.
Comfort and wearability
7.0
Handheld and ergonomic; the user controls placement and intensity. Some users report neck discomfort or jaw twitches at higher amplitudes.
Biofeedback and data
5.0
Counts and logs sessions on-device. No HRV measurement or external integration.
Value
5.5
Prescription pricing varies — typically ~$600 device plus refill cards; insurance coverage uneven. Not a casual purchase.
Pros
+The FDA-cleared non-invasive cervical VNS device for headache disorders
+The most headache RCTs here, mostly maker-sponsored (which ONDA does not count)
+Targets the cervical vagal trunk directly, not the auricular branch
+Clinically calibrated dosing — no guesswork
Cons
−Prescription-only in the US; gated by a physician
−Cost varies by payer; refill model can lock you in
Price: $600 prescription required; refill cards extra (as of 2026-05-21)
Where it leads
gammaCore Sapphire CV is the FDA-cleared non-invasive cervical vagus nerve stimulator for headache disorders — a different regulatory tier from the wellness devices in this list. It is cleared for migraine prevention and acute treatment (from age 12), cluster-headache acute and preventive treatment, and the rarer headache disorders paroxysmal hemicrania and hemicrania continua, backed by randomised controlled trials, mostly sponsored by electroCore. The device is held against the side of the neck over the carotid sheath and delivers a proprietary 5 kHz burst waveform for two-minute sessions; dosing is set clinically rather than by app.
What are the downsides of gammaCore Sapphire CV?
That same regulatory and clinical rigour limits its use. It is prescription-only, its indications are headache-specific, and there is no programme variety: dose, duration and waveform are fixed. It does not measure HRV, does not integrate with any health app, and at roughly six hundred dollars before refill cards it is expensive even before insurance enters the picture. As a wellness or general-recovery tool it is the wrong shape — Truvaga 350, made by the same company, exists for exactly that use case.
Who should buy gammaCore Sapphire CV?
Choose gammaCore if you have a clinical migraine or cluster-headache diagnosis and a prescriber who will write for it. For general HRV training, stress reduction or experimental tVNS, Nurosym (auricular, with consumer trials) or Truvaga 350 (cervical, OTC) are the right tools — not this one.
Background reading
The biology behind what these devices target — and the protocols that compound with the hardware.
Yes. In the US, gammaCore Sapphire CV is prescription-only, so access is gated by a physician. It is an FDA-cleared non-invasive cervical vagus nerve stimulator, and that clearance covers migraine (prevention and acute treatment, age 12+), cluster headache, paroxysmal hemicrania and hemicrania continua, not general wellness use.
How much does gammaCore cost?
gammaCore costs around $600, with refill cards extra. The actual cost varies by payer, and the refill model can lock you in over time. Because a prescription is required, you get it through a physician rather than as a simple retail purchase.
How does gammaCore work?
gammaCore is a handheld device you press against the side of the neck over the carotid artery. It delivers a proprietary 5 kHz waveform burst in fixed 2-minute sessions, targeting the cervical vagal trunk directly rather than the ear branch. Dosing is clinically calibrated, with no customisable protocols.
Is gammaCore worth it?
For clinically indicated migraine or cluster-headache patients, yes: it has the most headache RCTs of the devices here, mostly maker-sponsored (which ONDA does not count). For general stress relief or wellness it is the wrong tool, because it is a clinical device with narrow indications and prescription gating.
